Redcliffe Labs, a leading omnichannel Pan India
diagnostics service provider, has collaborated with Abbott India, a global
healthcare giant to introduce Clinical Decision Support (CDS) also known as
AlinIQ, powered by various proprietary technologies including Big Data Engines
and Artificial Intelligence (AI). This groundbreaking development aims to
revolutionize healthcare, offering promising solutions to enhance patient care and
convenience.
Redcliffe Labs has taken a significant step forward by becoming the first in the
diagnostics industry to adopt the newly launched AI-based AlinIQ Clinical
Decision Support system. The rollout took 24 months towards implementing the
advance platform. This cutting-edge technology empowers consumers but also
clinicians and other healthcare professionals with unparalleled insights and
recommendations, revolutionizing medical decisions.
In the modern healthcare landscape, the abundance of data, commonly known as
‘Big Data,’ poses challenges to clinical decision-making. Clinical high quality
laboratories platforms, like Redcliffe Labs, contribute significantly to this data
generation by continuously conducting advanced health tests for accurate
diagnosis. The complexity introduced by this vast information has increased the
burden on healthcare professionals. Redcliffe Labs aims to alleviate this burden,
enabling more efficient and informed decision-making for improved patient
outcomes.
Redcliffe Labs recognized the need to transform this vast data into meaningful,
actionable insights. The AI-powered CDS System bridges the gap, providing
healthcare professionals with user-friendly, personalized, and easy-to-interpret
information.

The CDS system goes beyond traditional laboratory reporting by utilizing AIdriven algorithms to apply decision-making to individual patient cases
automatically. It enables healthcare professionals to access scientific
interpretations based on clinical recommendations, providing enhanced insights for
better treatment decisions.
By adopting the latest AI technology, Redcliffe Labs is leading the way toward a
more personalized and precise approach to healthcare, contributing to a brighter
and healthier future for every Indian.
Redcliffe Labs, pioneering unwavering advancements in the diagnostic industry,
has consistently forged strategic partnerships with prominent healthcare and
technological brands, including Roche Diagnostics, Mongo DB, BD-Max MDR
TB, and Abbott. These collaborations share a common objective to provide
convenient, accurate, high-quality, and affordable diagnostic services to the people
of India, ensuring accessibility, affordability and excellence in healthcare.
“At Redcliffe Labs, our unwavering commitment to advancing patient care through
innovation and technology has led to the development of the AI based CDS
system,” stated Dheeraj Jain, Founder & MD of Redcliffe Labs. “Our state-ofthe-art CDS represents a giant leap forward in the diagnostic healthcare sector,
empowering our skilled clinicians with invaluable insights to provide the best
possible care for our patients.”
Mr. Jamshyed Patrawala, Country Head of Abbott India, emphasized that this
integration marks a significant milestone in the diagnostic industry, promising to
enhance the overall diagnostics landscape of the country. He believes this
advancement will greatly support clinicians and provide better convenience for
individuals, as they will receive comprehensive and personalized reports, unveiling
their comparative health condition.
The collaboration between Redcliffe Labs and Abbott has been instrumental in
successfully implementing the AlinIQ CDS system.
*Dr. Sohini Sengupta, Medical Laboratory Director at Redcliffe Labs,* led the
CDS project by enabling the customization of clinical guidelines, which will form
the basis for generating personalized patient-centric reports at Redcliffe Labs.
These were configured for over a year in close association with Dr. Shane Brown,
Clinical Consultant at Abbott.
In an era of digital transformation and personalized medicine, Redcliffe Labs’
pioneering initiative with the AI-based CDS System signifies a giant step towards
achieving value-based healthcare and enhancing the clinical care continuum for
every patient.